IPO5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6832091276342E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.26099999997464E-07 |
Normal-vs-Stage2 |
1.54377000000094E-05 |
Normal-vs-Stage3 |
1.66333613549341E-12 |
Normal-vs-Stage4 |
4.94430052455641E-10 |
Stage1-vs-Stage2 |
2.101200E-01 |
Stage1-vs-Stage3 |
8.22730000000771E-05 |
Stage1-vs-Stage4 |
1.401110E-03 |
Stage2-vs-Stage3 |
1.164020E-01 |
Stage2-vs-Stage4 |
2.009600E-01 |
Stage3-vs-Stage4 |
8.709000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.92748072847371E-13 |
Normal-vs-AfricanAmerican |
1.92139637533728E-11 |
Normal-vs-Asian |
2.004200E-01 |
Caucasian-vs-AfricanAmerican |
2.311700E-02 |
Caucasian-vs-Asian |
6.609400E-01 |
AfricanAmerican-vs-Asian |
1.339360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.13524769982132E-12 |
Normal-vs-Female |
6.51245724014871E-12 |
Male-vs-Female |
5.854600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.448100E-04 |
Normal-vs-Age(41-60Yrs) |
2.8181001976435E-10 |
Normal-vs-Age(61-80Yrs) |
5.00643970724468E-12 |
Normal-vs-Age(81-100Yrs) |
1.833310E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.802000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.813200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.907400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.585000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.854610E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.088400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.340150E-01 |
Normal-vs-Grade 2 |
1.93240000001538E-07 |
Normal-vs-Grade 3 |
2.31392682792375E-12 |
Normal-vs-Grade 4 |
1.64768199084619E-12 |
Grade 1-vs-Grade 2 |
7.136600E-01 |
Grade 1-vs-Grade 3 |
2.400800E-01 |
Grade 1-vs-Grade 4 |
1.057950E-02 |
Grade 2-vs-Grade 3 |
1.454000E-02 |
Grade 2-vs-Grade 4 |
3.10560000049698E-07 |
Grade 3-vs-Grade 4 |
2.196500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.778500E-04 |
Normal-vs-ccB subtype |
1.79090076102284E-12 |
ccA subtype-vs-ccB subtype |
2.61930000000632E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.02808905622487E-12 |
Normal-vs-N1 |
2.609500E-02 |
N0-vs-N1 |
7.252600E-01 |
|
|